You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0627 Rise-ssc: a double-blind, randomised study evaluating the efficacy and safety of riociguat for the treatment of patients with diffuse cutaneous systemic sclerosis

Alerts

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Scleroderma, myositis and related syndromes
AB0627 Rise-ssc: a double-blind, randomised study evaluating the efficacy and safety of riociguat for the treatment of patients with diffuse cutaneous systemic sclerosis
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address